C. Hurwitz

发表

The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia.

S. Lipsitz, S. Colan, R. Gelber, 2004, The New England journal of medicine.

Doxorubicin administration by continuous infusion is not cardioprotective: the Dana-Farber 91-01 Acute Lymphoblastic Leukemia protocol.

S. Lipsitz, S. Colan, R. Gelber, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Substituting dexamethasone for prednisone complicates remission induction in children with acute lymphoblastic leukemia

R. Gelber, S. Sallan, L. Silverman, 2000, Cancer.

AAML03P1, a pilot study of the safety of gemtuzumab ozogamicin in combination with chemotherapy for newly diagnosed childhood acute myeloid leukemia

S. Raimondi, R. Arceci, S. Meshinchi, 2012, Cancer.

Current Treatment and Results of St. Jude Studies for Childhood Acute Lymphoblastic Leukemia

M. Relling, W. Evans, R. Ribeiro, 1994 .

Safety and efficacy of gemtuzumab ozogamicin in combination with chemotherapy for pediatric acute myeloid leukemia: a report from the Children's Oncology Group.

I. Bernstein, R. Arceci, T. Alonzo, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Rituximab (anti-CD20) Adjunctive Therapy for Opsoclonus-Myoclonus Syndrome

M. Pranzatelli, B. Greffe, J. Mantovani, 2006, Journal of pediatric hematology/oncology.

A Phase I trial of bryostatin-1 in children with refractory solid tumors: a Pediatric Oncology Group study.

A. Kraft, M. Bernstein, R. Berkow, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Complete hematologic remissions induced by 2-chlorodeoxyadenosine in children with newly diagnosed acute myeloid leukemia.

R. Krance, R. Ribeiro, Raymond L. Blakley, 1994, Blood.

Phase II study of 2‐chlorodeoxyadenosine plus idarubicin for children with acute myeloid leukaemia in first relapse: a Paediatric Oncology Group study

T. Alonzo, Myron N. Chang, H. Weinstein, 2012, British journal of haematology.

Tretinoin toxicity in children with acute promyelocytic leukaemia

R. Krance, R. Ribeiro, V. Santana, 1993, The Lancet.

Use of [18F]fluorodeoxyglucose positron emission tomography in evaluating locally recurrent and metastatic adrenocortical carcinoma.

J. Wallis, R. Ribeiro, C. Rodríguez-Galindo, 2006, The Journal of clinical endocrinology and metabolism.

Prevalence and clinical implications of NRAS mutations in childhood AML: a report from the Children's Oncology Group

S. Raimondi, N. Heerema, S. Meshinchi, 2011, Leukemia.

Current strategies for treatment of acute myeloid leukemia at St Jude Children's Research Hospital.

M. Schell, R. Krance, M. Brenner, 1992, Leukemia.

Treatment of recurrent and refractory pediatric solid tumors with high-dose busulfan and cyclophosphamide followed by autologous bone marrow rescue.

C. Civin, P. Colombani, M. Wharam, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Caring for the child with cancer at the close of life: "there are people who make it, and I'm hoping I'm one of them".

J. Wolfe, C. Hurwitz, J. Duncan, 2004, JAMA.

A phase I trial of high-dose carboplatin and etoposide with autologous marrow support for treatment of relapse/refractory neuroblastoma without apparent bone marrow involvement: use of marker genes to investigate the biology of marrow reconstitution and the mechanism of relapse.

J. Ihle, R. Ribeiro, W. Furman, 1991, Human gene therapy.

A phase I trial of high-dose carboplatin and etoposide with autologous marrow support for treatment of stage D neuroblastoma in first remission: use of marker genes to investigate the biology of marrow reconstitution and the mechanism of relapse.

J. Ihle, R. Ribeiro, R. Moen, 1991, Human gene therapy.

Parents as Teachers: Teaching Pediatrics Residents the Art of Engaging in Difficult Conversations.

M. Smith, C. Hurwitz, Michelle Gallas, 2019, Journal of graduate medical education.

Phase I trial of paclitaxel in children with refractory solid tumors: a Pediatric Oncology Group Study.

M. Relling, Y. Ravindranath, C. Pratt, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prevalence and prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group.

S. Raimondi, J. Radich, N. Heerema, 2009, Blood.

Pulmonary insufficiency complicating therapy with high dose cytosine arabinoside in five pediatric patients with relapsed acute myelogenous leukemia

R. Krance, J. Jenkins, J. Laver, 1994, Cancer.

Update of St Jude Study XI for childhood acute lymphoblastic leukemia.

C. Pui, W. Furman, G. Rivera, 1992, Leukemia.

Autologous bone marrow transplant for children with AML in first complete remission: use of marker genes to investigate the biology of marrow reconstitution and the mechanism of relapse.

M. Schell, J. Ihle, R. Krance, 1991, Human gene therapy.

Invasive fungal disease in pediatric acute leukemia patients with fever and neutropenia during induction chemotherapy: a multivariate analysis of risk factors.

B. Leventhal, B. Corden, R. Baumgardner, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Removal of Phenytoin by Plasmapheresis in a Patient with Thrombotic Thrombocytopenia Purpura

J. Tobias, D. Baker, C. Hurwitz, 1992, Clinical pediatrics.

Preliminary Results of AML Therapy in Children Using Targeted Plasma Concentrations of Cytosine Arabinoside and Etoposide

M. Schell, R. Krance, C. Hurwitz, 1994 .

A pilot study of continuous infusion Ara-C in combination with rhG-CSF in relapsed childhood acute myeloid leukemia.

D. Srivastava, H. Weinstein, R. Krance, 1997, Leukemia & lymphoma.

Paclitaxel for the Treatment of Progressive or Recurrent Childhood Brain Tumors: A Pediatric Oncology Phase II Study

H. Friedman, J. Kepner, M. Harris, 2001, Journal of pediatric hematology/oncology.

XomaZyme-CD5 immunotoxin in conjunction with partial T cell depletion for prevention of graft rejection and graft-versus-host disease after bone marrow transplantation from matched unrelated donors.

R. Krance, H. Heslop, R. Ribeiro, 1994, Bone marrow transplantation.

Anti-pan T lymphocyte ricin A chain immunotoxin (H65-RTA) and methylprednisolone for acute GVHD prophylaxis following allogeneic BMT from HLA-identical sibling donors.

R. Krance, H. Heslop, R. Ribeiro, 1993, Bone marrow transplantation.

Role of irradiation in management of synovial sarcoma: St. Jude Children's Research Hospital experience.

A. Pappo, C. Pratt, D. Parham, 1996, Medical and pediatric oncology.

Invasive fungal disease in pediatric acute leukemia patients with fever and neutropenia during induction chemotherapy: a multivariate analysis of risk factors.

B. Leventhal, B. Corden, R. Baumgardner, 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical and microbiologic aspects of Staphylococcus haemolyticus infections

C. C. Patrick, T. Pearson, C. Hurwitz, 1993, The Pediatric Infectious Disease Journal.

Synovial sarcoma in children and adolescents: the St Jude Children's Research Hospital experience.

A. Pappo, C. Pratt, D. Parham, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Availability and use of palliative care and end-of-life services for pediatric oncology patients.

D. Johnston, J. Meza, D. Friedman, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prevalence and prognostic significance of KIT mutations in pediatric patients with core binding factor AML enrolled on serial pediatric cooperative trials for de novo AML.

I. Bernstein, S. Raimondi, J. Radich, 2010, Blood.

Height and weight in children treated for acute lymphoblastic leukemia: relationship to CNS treatment.

R. Gelber, S. Sallan, L. Cohen, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Favorable outcome for adolescents with acute lymphoblastic leukemia treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium Protocols.

M. Loh, D. Neuberg, S. Sallan, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia.

D. Neuberg, R. Gelber, S. Sallan, 2007, Blood.

Molecular alterations of the IDH1 gene in AML: a Children’s Oncology Group and Southwest Oncology Group study

I. Bernstein, S. Raimondi, J. Radich, 2010, Leukemia.

Clinical significance of CD10 expression in childhood acute lymphoblastic leukemia.

C. Pui, R. Ribeiro, W. Furman, 1993, Leukemia.

Mixed-lineage leukemia and asynchronous antigen expression.

C. Hurwitz, J. Mirro, J. Mirra, 1990, Hematology/oncology clinics of North America.

for children with acute lymphoblastic leukemia Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01

D. Neuberg, S. Sallan, S. Lipshultz, 2013 .

Secondary acute myeloid leukemia in children previously treated with alkylating agents, intercalating topoisomerase II inhibitors, and irradiation.

F. Behm, S. Raimondi, C. Pui, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Distinctive immunophenotypic features of t(8;21)(q22;q22) acute myeloblastic leukemia in children.

F. Behm, S. Raimondi, G. Ayers, 1992, Blood.

Asynchronous Antigen Expression in B Lineage Acute Lymphoblastic Leukemia

M. Borowitz, J. Karp, C. Civin, 1988 .

Asynchronous antigen expression in B lineage acute lymphoblastic leukemia.

M. Borowitz, J. Karp, C. Civin, 1988, Blood.

Saturable pharmacokinetics and paclitaxel pharmacodynamics in children with solid tumors.

J J Shuster, M. Relling, J. Shuster, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Experience with 2-chlorodeoxyadenosine in previously untreated children with newly diagnosed acute myeloid leukemia and myelodysplastic diseases.

S. Raimondi, R. Krance, R. Ribeiro, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prognostic implications of the IDH1 synonymous SNP rs11554137 in pediatric and adult AML: a report from the Children's Oncology Group and SWOG.

I. Bernstein, S. Raimondi, J. Radich, 2011, Blood.

Treatment of Patients with Acute Myelogenous Leukemia: Review of Clinical Trials of the Past Decade

H. Grier, C. Hurwitz, K. Mounce, 1995, Journal of pediatric hematology/oncology.

Prevalence and Clinical Implications of N-RAS Mutations in Childhood AML – A Report From the Children's Oncology Group.

S. Raimondi, J. Radich, N. Heerema, 2009 .

CEBPA Mutations Predict Favorable Prognosis in Pediatric AML

S. Raimondi, J. Radich, N. Heerema, 2008 .

Treatment o f C hildhood A cute L ymphoblastic L eukemia: Results o f D ana-Farber A LL C onsortium P rotocol 8 7-01

R. Gelber, S. Sallan, L. Silverman, 2002 .

Treatment of childhood acute lymphoblastic leukemia: results of Dana-Farber ALL Consortium Protocol 87-01.

R. Gelber, S. Sallan, L. Silverman, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prognostic importance of immunophenotyping in adults with acute myelocytic leukaemia: the significance of the stem‐cell glycoprotein CD34 (My 10)

S. Piantadosi, M. Zahurak, J. Karp, 1990, British journal of haematology.

COG AAML03P1: Efficacy and Safety in a Pilot Study of Intensive Chemotherapy Including Gemtuzumab in Children Newly Diagnosed with Acute Myeloid Leukemia (AML)

S. Raimondi, R. Arceci, S. Meshinchi, 2008 .

Flow cytometric detection of rare normal human marrow cells with immunophenotypes characteristic of acute lymphoblastic leukemia cells.

C. Civin, K. Stone, S. Gore, 1992, Leukemia.

Acute megakaryoblastic leukemia in children and adolescents: a retrospective analysis of 24 cases.

F. Behm, S. Raimondi, D. Fairclough, 1993, Leukemia & lymphoma.

Adverse prognostic features in 251 children treated for acute myeloid leukemia.

C. Pui, M. Schell, W. Crist, 1993, Medical and pediatric oncology.

Diffuse alveolar hemorrhage associated with Mycoplasma hominis respiratory tract infection in a bone marrow transplant recipient.

R. Krance, J. Shenep, C. Hurwitz, 1994, Chest.

High expression of the very late antigen-4 integrin independently predicts reduced risk of relapse and improved outcome in pediatric acute myeloid leukemia: a report from the children's oncology group.

S. Raimondi, S. Meshinchi, T. Alonzo, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Final results of a prospective clinical trial with VAMP and low-dose involved-field radiation for children with low-risk Hodgkin's disease.

S. Brain, S. Rai, M. Hudson, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Risk-adapted, combined-modality therapy with VAMP/COP and response-based, involved-field radiation for unfavorable pediatric Hodgkin's disease.

T. Merchant, S. Rai, M. Hudson, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

N-CAM (CD56) expression by CD34+ malignant myeloblasts has implications for minimal residual disease detection in acute myeloid leukemia.

F. Behm, D. Campana, E. Coustan-Smith, 1993, Leukemia.

Etoposide (VP-16) Disposition in Children with Acute Myeloblastic Leukemia

T. Madden, C. Hurwitz, J. Mirro, 1994 .

VAMP and low-dose, involved-field radiation for children and adolescents with favorable, early-stage Hodgkin's disease: results of a prospective clinical trial.

K. Lamborn, M. Hudson, S. Donaldson, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01.

R. Gelber, S. Sallan, L. Silverman, 2001, Blood.

Cognitive sequelae in children treated for acute lymphoblastic leukemia with dexamethasone or prednisone.

S. Sallan, L. Silverman, N. Tarbell, 2000, Journal of pediatric hematology/oncology.

Effects of recombinant human hematopoietic growth factors on leukemic blasts from children with acute myeloblastic or lymphoblastic leukemia.

F. Behm, S. Raimondi, J. Ihle, 1993, Leukemia.

Parenteral nutrition associated with increased infection rate in children with cancer

J. Gattuso, M. Hancock, B. Pharm., 1993, Cancer.